Home/Filings/4/0001860008-25-000005
4//SEC Filing

Telman Deborah H 4

Accession 0001860008-25-000005

CIK 0000882095other

Filed

Sep 10, 8:00 PM ET

Accepted

Sep 11, 7:31 PM ET

Size

8.4 KB

Accession

0001860008-25-000005

Insider Transaction Report

Form 4
Period: 2025-09-10
Telman Deborah H
EVP, Corporate Affairs & GC
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2025-09-101,31520,331 total
    Common Stock (1,315 underlying)
  • Exercise/Conversion

    Common Stock

    2025-09-10+1,31544,036 total
  • Tax Payment

    Common Stock

    2025-09-10$115.25/sh634$73,06943,402 total
Footnotes (2)
  • [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
  • [F2]The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

Issuer

GILEAD SCIENCES, INC.

CIK 0000882095

Entity typeother

Related Parties

1
  • filerCIK 0001860008

Filing Metadata

Form type
4
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 7:31 PM ET
Size
8.4 KB